Terms: = Kidney tumors AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
10 results:
1. Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer.
Milane LS; Dolare S; Ren G; Amiji M
J Control Release; 2023 Nov; 363():435-451. PubMed ID: 37717658
[TBL] [Abstract] [Full Text] [Related]
2. Characterizing clinicopathological findings of transarterial chemoembolization for Wilms tumor.
Li JP; Chu JP; Oh P; Li Z; Chen W; Huang YH; Yang JY
J Urol; 2010 Mar; 183(3):1138-44. PubMed ID: 20096886
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
[TBL] [Abstract] [Full Text] [Related]
4. The pT1a and pT1b category subdivision in renal cell carcinoma: is it reflected by differences in tumour biology?
Langner C; Ratschek M; Rehak P; Tsybrovskyy O; Zigeuner R
BJU Int; 2005 Feb; 95(3):310-4. PubMed ID: 15679784
[TBL] [Abstract] [Full Text] [Related]
5. Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.
Lee CT; Genega EM; Hutchinson B; Fearn PA; Kattan MW; Russo P; Reuter VE
Urol Oncol; 2003; 21(3):179-84. PubMed ID: 12810203
[TBL] [Abstract] [Full Text] [Related]
6. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T
Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612
[TBL] [Abstract] [Full Text] [Related]
7. Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.
Oudard S; Levalois C; Andrieu JM; Bougaran J; Validire P; Thiounn N; Poupon MF; Fourme E; Chevillard S
Anticancer Res; 2002; 22(1A):121-8. PubMed ID: 12017273
[TBL] [Abstract] [Full Text] [Related]
8. clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.
Uchida T; Gao JP; Wang C; Jiang SX; Muramoto M; Satoh T; Minei S; Shimura S; Irie A; Kameya T; Baba S
Urology; 2002 Apr; 59(4):615-20. PubMed ID: 11927338
[TBL] [Abstract] [Full Text] [Related]
9. The prognostic significance of apoptosis-associated proteins bcl-2, BAX and BCL-X in clinical nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ
Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445
[TBL] [Abstract] [Full Text] [Related]
10. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway.
Morimitsu Y; Nakajima M; Hisaoka M; Hashimoto H
APMIS; 2000 Sep; 108(9):617-25. PubMed ID: 11110050
[TBL] [Abstract] [Full Text] [Related]